The trajectory of the erectile dysfunction drug presents a challenging picture for those considering investment. While the initial launch generated massive gains, the lapse of its patent opened the avenue to generic https://worldlistpro.com/story23720695/the-copyright-and-big-pharma-a-volatile-investment